| 尼莫通防治蛛网膜下腔出血后脑血管痉挛的疗效观察 |
| |
| 引用本文： | 吕友梅,武前文,詹月红. 尼莫通防治蛛网膜下腔出血后脑血管痉挛的疗效观察[J]. 辽宁医学院学报, 1999, 20(4): 10-13 |
| |
| 作者姓名： | 吕友梅 武前文 詹月红 |
| |
| 作者单位： | 1. 淮南矿院医学分院附属医院
2. 苏州医学院第一附属医院,江苏,苏州,215007 |
| |
| 摘 要： | 对８０例蛛网膜下腔出血患者进行尼莫通治疗效果的对照研究，结果显示：治疗组２周内临床症状、体征缓解／消失率明显高于对照组，而１个月后致残、致死率明显低于对照组。结论：尼莫通是防治蛛网膜下腔出血后脑血管痉挛的有效药物，发病后早期应用可提高疗效，降低致残、致死率。
|
| 关 键 词： | 蛛网膜下腔出血 脑血管痉挛 尼莫通 |
OBSERVATION OF THERAPEUTIC EFFECT OF NIMOTOP TO PREVENT AND TREAT CEREBRAL VASCULAR SPASM CAUSED BY SAH |
| |
| Lu Youmei,Wu Qianwen,et al. OBSERVATION OF THERAPEUTIC EFFECT OF NIMOTOP TO PREVENT AND TREAT CEREBRAL VASCULAR SPASM CAUSED BY SAH[J]. Journal of Liaoning Medical University (LNMU) Bimonthly, 1999, 20(4): 10-13 |
| |
| Authors: | Lu Youmei Wu Qianwen et al |
| |
| Abstract: | The compare study about the effect of Nimotop was made by us in 80 patients with SAH The result showed that the relief or disappearance rate of clinical syndroms and signs in 40 patients of treatment group was much higher than that of 40 patients of control group within two weeks After one month the disability and mortality rate in therapy group was much lower than the control group Conclusions:Nimotop is an effective drug in preventing and treating cerebral vascular spasm causde by SAH Early usage of Nimotop can improve the clinical effect and decrease disability and mortality rate |
| |
| Keywords: | SAH cerebral vascular spasm Nimotop |
| 本文献已被 CNKI 维普 万方数据 等数据库收录！ |
